COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.

Spiera, Emily; Agrawal, Manasi; Ungaro, Ryan C

Spiera, Emily; Agrawal, Manasi; Ungaro, Ryan C.

Spiera E; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Agrawal M; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Ungaro RC; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.

Gastroenterology ; 162(3): 987-988, 2022 03.

Article in English | MEDLINE | ID: covidwho-1598323

Subject(s)

COVID-19; Inflammatory Bowel Diseases; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Inflammatory Bowel Diseases/drug therapy; Inflammatory Bowel Diseases/immunology; SARS-CoV-2; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google